Search research articles
Contact Us
Filters
Showing results (191-200 of 442) with videos related to
Page
of 45
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
May 25, 2012
Nonmelanoma skin cancers among HIV-infected persons in the HAART era
Elisa Garlassi, Victoria Harding, Justin Weir, et al.
Blood
|
March 5, 2004
Hepatitis B reactivation during combination chemotherapy for AIDS-related lymphoma is uncommon and does not adversely affect outcome
Justin Stebbing, Mark Atkins, Mark Nelson, et al.
Journal of HIV Therapy
|
October 27, 2007
Guillain--Barre syndrome following immune reconstitution after antiretroviral therapy for primary HIV infection
E C Y Teo, A Azwra, R L Jones, et al.
AIDS (London, England)
|
June 5, 2007
Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patients
Guglielmo Rosignoli, Alison Cranage, Catherine Burton, et al.
Blood
|
February 20, 2009
Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease
Mark Bower, Ophelia Veraitch, Richard Szydlo, et al.
Blood
|
November 21, 2007
Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease
Tom Powles, Justin Stebbing, Silvia Montoto, et al.
BMC Family Practice
|
December 15, 2019
Patient-reported GP health assessments rather than individual cardiovascular risk burden are associated with the engagement in lifestyle changes: population-based survey in South Australia
David Alejandro Gonzalez-Chica, Jacqueline Bowden, Caroline Miller, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 27, 2005
The effect of statins on HIV rebound and blips
Laura Waters, Justin Stebbing, Rachael Jones, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 10, 2016
Evolution of HIV-Associated Lymphoma Over 3 Decades
Ramya Ramaswami, Germaine Chia, Alessia Dalla Pria, et al.
AIDS (London, England)
|
July 11, 2003
A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma
Simon Portsmouth, Justin Stebbing, Jas Gill, et al.
Page
of 45
Search research articles
Search
Showing results (191-200 of 442) with videos related to
Sort By:
Page
of 45
Journal of Acquired Immune Deficiency Syndromes (1999)
|
May 25, 2012
Nonmelanoma skin cancers among HIV-infected persons in the HAART era
Elisa Garlassi, Victoria Harding, Justin Weir, et al.
Blood
|
March 5, 2004
Hepatitis B reactivation during combination chemotherapy for AIDS-related lymphoma is uncommon and does not adversely affect outcome
Justin Stebbing, Mark Atkins, Mark Nelson, et al.
Journal of HIV Therapy
|
October 27, 2007
Guillain--Barre syndrome following immune reconstitution after antiretroviral therapy for primary HIV infection
E C Y Teo, A Azwra, R L Jones, et al.
AIDS (London, England)
|
June 5, 2007
Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patients
Guglielmo Rosignoli, Alison Cranage, Catherine Burton, et al.
Blood
|
February 20, 2009
Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease
Mark Bower, Ophelia Veraitch, Richard Szydlo, et al.
Blood
|
November 21, 2007
Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease
Tom Powles, Justin Stebbing, Silvia Montoto, et al.
BMC Family Practice
|
December 15, 2019
Patient-reported GP health assessments rather than individual cardiovascular risk burden are associated with the engagement in lifestyle changes: population-based survey in South Australia
David Alejandro Gonzalez-Chica, Jacqueline Bowden, Caroline Miller, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 27, 2005
The effect of statins on HIV rebound and blips
Laura Waters, Justin Stebbing, Rachael Jones, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 10, 2016
Evolution of HIV-Associated Lymphoma Over 3 Decades
Ramya Ramaswami, Germaine Chia, Alessia Dalla Pria, et al.
AIDS (London, England)
|
July 11, 2003
A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma
Simon Portsmouth, Justin Stebbing, Jas Gill, et al.
Page
of 45